Open Access

Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro

  • Authors:
    • Fuben Xu
    • Huayu Wu
    • Kun Zhang
    • Peizhen Lv
    • Li Zheng
    • Jinmin Zhao
  • View Affiliations

  • Published online on: September 6, 2016     https://doi.org/10.3892/mmr.2016.5717
  • Pages: 3573-3580
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Nerve regeneration remains a challenge to the treatment of peripheral nerve injury. Andrographolide (Andro) is the main active constituent of Andrographis paniculata, which has been applied in the treatment of several diseases, including inflammation, in ancient China. Andro has been reported to facilitate the reduction of edema and to exert analgesic effects in the treatment of various diseases. These findings suggest that Andro may be considered a promising anti‑inflammatory agent that may suppress destruction and accelerate proliferation of Schwann cells following peripheral nerve injury. In the present study, the effects of Andro on RSC96 cells were investigated in vitro. The RSC96 cell line is a spontaneously immortalized rat Schwann cell line, which was originally derived from a long‑term culture of rat primary Schwann cells. RSC96 cells were treated with a range of 0 to 50 µM Andro prior to the MTT assay. Cell proliferation, morphology, synthesis and nerve‑specific gene expression were performed to detect the effect of Andro on RSC96 cells. The results of the present study demonstrated that the recommended doses of Andro ranged between 0.78 and 12.5 µM, among which the most obvious response was observed when used at 3.125 µM (P<0.05). DNA content was improved in Andro groups compared with the control group (P<0.05). In addition, Andro was able to promote the gene expression of glial cell line‑derived neurotrophic factor, brain‑derived neurotrophic factor, ciliary neurotrophic factor, and the specific Schwann cell marker S100β (P<0.05). The results of a viability assay, hematoxylin‑eosin staining, and immunohistochemistry were also improved in Andro groups. These results indicated that Andro may accelerate proliferation of RSC96 cells in vitro, whilst maintaining the Schwann cell phenotype; therefore, the present study may provide valuable evidence for the further exploration of the effects of Andro on peripheral nerves.
View Figures
View References

Related Articles

Journal Cover

October-2016
Volume 14 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu F, Wu H, Zhang K, Lv P, Zheng L and Zhao J: Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro. Mol Med Rep 14: 3573-3580, 2016.
APA
Xu, F., Wu, H., Zhang, K., Lv, P., Zheng, L., & Zhao, J. (2016). Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro. Molecular Medicine Reports, 14, 3573-3580. https://doi.org/10.3892/mmr.2016.5717
MLA
Xu, F., Wu, H., Zhang, K., Lv, P., Zheng, L., Zhao, J."Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro". Molecular Medicine Reports 14.4 (2016): 3573-3580.
Chicago
Xu, F., Wu, H., Zhang, K., Lv, P., Zheng, L., Zhao, J."Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro". Molecular Medicine Reports 14, no. 4 (2016): 3573-3580. https://doi.org/10.3892/mmr.2016.5717